It restores mitochondrial function, reduces micronuclei, promotes p53-mediated apoptosis, and reduces fibrosis, highlighting STING as a promising therapeutic target in ADPKD [160]. The gene discussed is STING1; the disease is autosomal dominant polycystic kidney disease.